Filipe Pereira
- Division of Molecular Medicine and Gene Therapy
- Cell Reprogramming in Hematopoiesis and Immunity
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- WCMM-Wallenberg Centre for Molecular Medicine
- LUCC: Lund University Cancer Centre
1 – 10 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Transcription factor-mediated reprogramming to antigen-presenting cells
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Reprogramming Stars #14 : Fast-Forwarding Cellular Reprogramming- An Interview with Dr. Mark Kotter
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #16 : Reprogramming, from Cells to Embryos-An Interview with Dr. José Silva
(
- Contribution to journal › Article
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #18 : Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall
(
- Contribution to journal › Letter
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Orchestrating an immune response to cancer with cellular reprogramming
(
- Contribution to journal › Letter
-
Mark
Reprogramming Stars #19 : Upgrading Cell Fate Conversions with Engineered Reprogramming Factors-An Interview with Dr. Ralf Jauch
(
- Contribution to journal › Article
-
Mark
HMGA1 stimulates cancer stem-like features and sensitivity to monensin in gastric cancer
(
- Contribution to journal › Article